SXTP: 60 Degrees Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.79
Enterprise Value ($M) 10.59
Book Value ($M) 4.80
Book Value / Share 0.41
Price / Book 0.58
NCAV ($M) 4.26
NCAV / Share 0.37
Price / NCAV 0.66

Profitability (mra)
Return on Invested Capital (ROIC) -0.76
Return on Assets (ROA) -0.50
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.39
Current Ratio 2.55

Balance Sheet (mrq) ($M)
Current Assets 7.24
Assets 7.78
Liabilities 2.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.25
Operating Income -5.15
Net Income -3.77

Cash Flow Statement (mra) ($M)
Cash From Operations -4.54
Cash from Investing -0.12
Cash from Financing 6.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-18 13G Knight Therapeutics (Barbados) Inc. 19.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(
2023-11-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 ☐ TRANSITION REPO
2023-08-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 ☐ TRANSITION REPORT PU

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 141,609 770,171 18.39
2024-05-01 1,925 34,797 5.53
2024-04-30 7,865 18,379 42.79
2024-04-29 3,419 4,734 72.22

(click for more detail)

Similar Companies
SPRC – SciSparc Ltd. SRZN – Surrozen, Inc.
SXTC – China SXT Pharmaceuticals, Inc. SYBX – Synlogic, Inc.
TCON – TRACON Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io